<DOC>
	<DOCNO>NCT02144727</DOCNO>
	<brief_summary>In oncological aspect , D1+ lymph node dissection would enough early stage gastric cancer advance gastric cancer ( stage IB/IIA/IIB ) .</brief_summary>
	<brief_title>A Clinical Trial D1+ Versus D2 Distal Gastrectomy Stage IB &amp; II Advanced Gastric Cancer</brief_title>
	<detailed_description>■ Background Hypothesis A. JCOG ( Japanese Clinical Oncology Group ) 9501 Study : Addition aorta lymph node dissection D2 lymph node dissection increase survival rate . Wide range operation always best treatment . If invasion rate keep minimal possible maintain survival rate , lead secure operation also reduce frequency complication surgery . 20 It may advantageous patient term operation time , cost , quality life . B. COACT 1001 study A previous study compare feasibility lymph node dissection open surgery lapraroscopic surgery advance gastric cancer . 11p , 12a lymph node ( D2 ) resection rate : 79.2 % 88.8 % respectively advance gastric cancer . 11p , 12a lymph node ( D2 ) metastasis rate : 1.9 % 2.9 % respectively . Subgroup analysis 11p , 12a lymph node resection cStage IB/IIA : 74.5-80.0 % 86.7-96.1 % respectively . : 0 % metastasis rate . lymph node dissection cStage IIB/IIIA : 81.1-82.3 % 87.5-89.2 % respectively . : metastasis rate 2.1 % 2.4-12.1 % respectively . Application : 11p 12a lymph node , belong D2 lymph node , need resect advance gastric cancer IIB stage high . However , early stage advance gastric cancer , probability metastasis low ; therefore , resection D1+ lymph node , exclude 11p 12a , enough .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Inclusion Criteria : Histologically proven primary gastric adenocarcinoma T1N1 , T2N0 , T2N1 , T3N0 , T3N1 CT scan ( AJCC 7th classification ) intraoperative surgical staging prior resectional procedure Location primary tumor ; antrum , angle , low body mid body stomach No evidence distant metastasis Aged ≥ 20 year old Performance status ( PS ) 0 1 Eastern Cooperative Oncology Group ( ECOG ) scale No prior treatment chemotherapy radiation therapy malignancy , prior treatment gastric cancer include endoscopic mucosal resection Adequate organ function define indicated : WBC 3000/mm3 12,000/mm3 &gt; serum Hemoglobin 8.0 g/dl &gt; serum Platelet 100 000/mm3 &lt; serum AST 100 IU/l &lt; serum ALT 100 IU/l &lt; Total Bilirubin 2.0 mg/dl Written sign inform consent Exclusion Criteria : Active double cancer ( synchronous double cancer metachronous double cancer within five diseasefree year ) , exclude carcinoma situ ( lesion equal intraepithelial intramucosal cancer ) Gastric remnant cancer ≥T4a surgical stag resection N2 ( number metastatic lymph node ≥3 ) CT scan Histologically rare variant WHO Classification Adenosquamous , Hepatoid , Squamous cell , Undifferentiated , , neuroendocrine carcinoma others Pregnant breastfeed woman Mental disorder ( diagnosed mental disorder medical record ) systemic administration corticosteroid ( include Herbal Medication ) unstable angina myocardial infarction within 6 month trial unstable hypertension severe respiratory disease require continuous oxygen therapy previous upper abdominal surgery except laparoscopic cholecystectomy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>